These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 16324219)
1. Neogenin expression may be inversely correlated to the tumorigenicity of human breast cancer. Lee JE; Kim HJ; Bae JY; Kim SW; Park JS; Shin HJ; Han W; Kim SW; Kang KS; Noh DY BMC Cancer; 2005 Dec; 5():154. PubMed ID: 16324219 [TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer. Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230 [TBL] [Abstract][Full Text] [Related]
3. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines. Jiang Y; Tong D; Lou G; Zhang Y; Geng J Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070 [TBL] [Abstract][Full Text] [Related]
4. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours. Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564 [TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic proteins 1 to 7 in human breast cancer, expression pattern and clinical/prognostic relevance. Davies SR; Watkins G; Douglas-Jones A; Mansel RE; Jiang WG J Exp Ther Oncol; 2008; 7(4):327-38. PubMed ID: 19227012 [TBL] [Abstract][Full Text] [Related]
6. [Screening of a sub-clone of human breast cancer cells with high metastasis potential]. Ye LH; Wu LY; Guo W; Ma HT; Zhang XD Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):61-5. PubMed ID: 16606541 [TBL] [Abstract][Full Text] [Related]
7. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival. Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124 [TBL] [Abstract][Full Text] [Related]
8. HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection. Li Y; Xu J; Chen L; Zhong WD; Zhang Z; Mi L; Zhang Y; Liao CG; Bian HJ; Jiang JL; Yang XM; Li XY; Fan CM; Zhu P; Fu L; Chen ZN Histopathology; 2009 May; 54(6):677-87. PubMed ID: 19438743 [TBL] [Abstract][Full Text] [Related]
9. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R; Schaaf A Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473 [TBL] [Abstract][Full Text] [Related]
10. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study. Salvucci O; Bouchard A; Baccarelli A; Deschênes J; Sauter G; Simon R; Bianchi R; Basik M Breast Cancer Res Treat; 2006 Jun; 97(3):275-83. PubMed ID: 16344916 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer. Xu X; Wang B; Ye C; Yao C; Lin Y; Huang X; Zhang Y; Wang S Cancer Lett; 2008 Mar; 261(2):147-57. PubMed ID: 18171602 [TBL] [Abstract][Full Text] [Related]
12. Expression of syndecan-1 in paired samples of normal and malignant breast tissue from postmenopausal women. Lofgren L; Sahlin L; Jiang S; Von Schoultz B; Fernstad R; Skoog L; Von Schoultz E Anticancer Res; 2007; 27(5A):3045-50. PubMed ID: 17970043 [TBL] [Abstract][Full Text] [Related]
13. The expression and function of IGFBP-3 in normal and malignant breast tissue. McCarthy K; Laban C; McVittie CJ; Ogunkolade W; Khalaf S; Bustin S; Carpenter R; Jenkins PJ Anticancer Res; 2009 Oct; 29(10):3785-90. PubMed ID: 19846909 [TBL] [Abstract][Full Text] [Related]
14. Claudin-16 reduces the aggressive behavior of human breast cancer cells. Martin TA; Harrison GM; Watkins G; Jiang WG J Cell Biochem; 2008 Sep; 105(1):41-52. PubMed ID: 18442037 [TBL] [Abstract][Full Text] [Related]
15. Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients. Holm C; Rayala S; Jirström K; Stål O; Kumar R; Landberg G J Natl Cancer Inst; 2006 May; 98(10):671-80. PubMed ID: 16705121 [TBL] [Abstract][Full Text] [Related]
16. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer. Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375 [TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer. Jiang WG; Douglas-Jones AG; Mansel RE Prostaglandins Leukot Essent Fatty Acids; 2006 Feb; 74(2):125-34. PubMed ID: 16364620 [TBL] [Abstract][Full Text] [Related]
18. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer. Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304 [TBL] [Abstract][Full Text] [Related]
19. Alterations in the expression of PDCD4 in ductal carcinoma of the breast. Wen YH; Shi X; Chiriboga L; Matsahashi S; Yee H; Afonja O Oncol Rep; 2007 Dec; 18(6):1387-93. PubMed ID: 17982621 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional and translational modulation of KAI1 expression in ductal carcinoma of the breast and the prognostic significance. Malik FA; Sanders AJ; Jones AD; Mansel RE; Jiang WG Int J Mol Med; 2009 Feb; 23(2):273-8. PubMed ID: 19148553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]